<DOC>
	<DOC>NCT00853645</DOC>
	<brief_summary>Primary objective is to evaluate the safety and performance of the implanted S-ICD system. A maximum of 10 subjects were to be enrolled and followed for one month to collect data on the safety, efficacy, and performance of the implanted S-ICD system. Additionally, patient comfort will be assessed as will cosmetic outcome.</brief_summary>
	<brief_title>Initial Chronic Human Validation Study: Subcutaneous Implantable (S-ICD) System</brief_title>
	<detailed_description />
	<criteria>replacement of an existing transvenouse ICD system ACC/AHA/HRS Class I or II indications for ICD implantation Age &gt;= 18 years Appropriate preoperative ECG as measured with a specially developed template Subjects unable or unwilling to provide informed consent Any condition which precludes the subject's ability to comply with the study requirements Remales who are pregnant or lactating and premenopausal women who are unwilling to use adequate birth control for the duration of the study Participation in another investigational device trial at any time during the conduct of the SICD system trial without written consent from the sponsor. Patients with a serious medical condition and life expectancy of less than one year. Patients with documented spontaneous and frequently recurring VT that is reliably terminated with antitachycardia pacing Patients with existing epicardial patches or subcutaneous electrodes in the left thoracic quadrant Patients with chronic renal failure, i.e. with a creatinine level of &gt;2.5 mg/dl unless prescribed drug therapy known to increase creatinine levels in which case the value should be &lt;= 3mg/dl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>